Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches

Merve Cakir; Kirsten Obernier; Antoine Forget; Nevan J. Krogan

doi:10.1128/mSystems.00388-21

mSystems (Oct 2021)

Target Discovery for Host-Directed Antiviral Therapies: Application of Proteomics Approaches

Merve Cakir,
Kirsten Obernier,
Antoine Forget,
Nevan J. Krogan

Affiliations

Merve Cakir: Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA
Kirsten Obernier: Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA
Antoine Forget: Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA
Nevan J. Krogan: Quantitative Biosciences Institute (QBI), University of California, San Francisco, California, USA

DOI: https://doi.org/10.1128/mSystems.00388-21
Journal volume & issue: Vol. 6, no. 5

Abstract

Read online

Current epidemics, such as HIV or influenza, and the emergence of new threatening pathogens, such as the one causing the current coronavirus disease 2019 (COVID-19) pandemic, represent major global health challenges. While vaccination is an important part of the arsenal to counter the spread of viral diseases, it presents limitations and needs to be complemented by efficient therapeutic solutions.

Published in mSystems

ISSN: 2379-5077 (Online)
Publisher: American Society for Microbiology
Country of publisher: United States
LCC subjects: Science: Microbiology
Website: https://journals.asm.org/journal/msystems

About the journal